Is Higher Dose of Inhaled Treprostinil Truly Superior to Lower Dose of Inhaled Treprostinil in Patients With Pulmonary Hypertension Associated With Interstitial Lung Diseases?

被引：0
|
作者：
Genecand, Leon [1 ]
Lador, Frederic [1 ]
Montani, David [2 ]
Perneger, Thomas [3 ,4 ]
机构：
[1] Univ Hosp Geneva, Dept Med, Div Pneumol, Geneva, Switzerland
[2] Univ Paris Saclay, Hop Bicetre, Pulm Hypertens Natl Referral Ctr, AP AP,Dept Resp & Intens Care Med,INSERM,UMR S 999, Gif Sur Yvette, France
[3] Univ Geneva, Dept Hlth & Community Med, Div Clin Epidemiol, Geneva, Switzerland
[4] Univ Hosp Geneva, Geneva, Switzerland
来源：
CHEST | 2024年 / 165卷 / 05期
关键词：
D O I：
10.1016/j.chest.2023.12.032
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
引用
收藏
页码：e161 / e161
页数：1
相关论文
共 50 条
  • [31] Inhaled Treprostinil in Group 3 Pulmonary Hypertension REPLY
    Nathan, Steven D.
    Waxman, Aaron
    Tapson, Victor
    NEW ENGLAND JOURNAL OF MEDICINE, 2021, 384 (19): : 1871 - 1872
  • [32] Inhaled Treprostinil in Group-3 Pulmonary Hypertension
    Agarwal, M.
    Waxman, A. B.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2015, 34 (04): : S343 - S343
  • [33] Inhaled treprostinil sodium for the treatment of pulmonary arterial hypertension
    Ferrantino, Matthew
    White, R. James
    EXPERT OPINION ON PHARMACOTHERAPY, 2011, 12 (16) : 2583 - 2593
  • [34] Inhaled treprostinil sodium (TRE) for the treatment of pulmonary hypertension
    Voswinckel, R
    Enke, B
    Kreckel, A
    Reichenberger, F
    Krick, S
    Gall, H
    Gessler, T
    Schmehl, T
    Kohstall, MG
    Grimminger, F
    Ghofrani, HA
    Seeger, W
    Olschewski, H
    CIRCULATION, 2004, 110 (17) : 295 - 295
  • [35] The impact of comorbidities on inhaled treprostinil treatment in patients with pulmonary arterial hypertension
    Argula, Rahul
    Shapiro, Shelley
    El-Kersh, Karim
    Shen, Eric
    Kim, Hyoshin
    Broderick, Meredith
    Mclaughlin, Vallerie
    EUROPEAN RESPIRATORY JOURNAL, 2023, 62
  • [36] Safety and efficacy of transition from inhaled treprostinil to parenteral treprostinil in selected patients with pulmonary arterial hypertension
    Preston, Ioana R.
    Feldman, Jeremy
    White, James
    Franco, Veronica
    Ishizawar, David
    Burger, Charles
    Waxman, Aaron B.
    Hill, Nicholas S.
    PULMONARY CIRCULATION, 2014, 4 (03) : 456 - 461
  • [37] Inhaled treprostinil is a potent pulmonary vasodilator in severe pulmonary hypertension
    Voswinckel, R
    Kohstall, MG
    Enke, B
    Gessler, T
    Reichenberger, F
    Ghofrani, HA
    Seeger, W
    Olschewski, H
    EUROPEAN HEART JOURNAL, 2004, 25 : 22 - 22
  • [38] Inhaled treprostinil in patients with pulmonary hypertension associated with interstitial lung disease with less severe haemodynamics: a post hoc analysis of the INCREASE study
    Weatherald, Jason
    Nathan, Steven D.
    El-Kersh, Karim
    Argula, Rahul G.
    DuBrock, Hilary M.
    Rischard, Franz P.
    Cassady, Steven J.
    Tarver, James
    Levine, Deborah J.
    Tapson, Victor F.
    Deng, Chunqin
    Shen, Eric
    Das, Manisit
    Waxman, Aaron B.
    BMJ OPEN RESPIRATORY RESEARCH, 2024, 11 (01)
  • [39] Safety and tolerability of inhaled treprostinil with phosphodiesterase-5 inhibitors in patients with pulmonary hypertension due to interstitial lung disease
    Zisman, David
    Dubrock, Hilary
    King, Christopher
    Weaver, Sheila
    Nathan, Steven
    Rahaghi, Franck
    Kim, Hyoshin
    Rao, Youlan
    Shen, Eric
    Waxman, Aaron
    EUROPEAN RESPIRATORY JOURNAL, 2023, 62
  • [40] INHALED TREPROSTINIL FOR THE TREATMENT OF CONNECTIVE TISSUE-ASSOCIATED PULMONARY ARTERIAL HYPERTENSION
    Highland, Kristin B.
    McLaughlin, Vallerie
    Chin, Kelly
    Ataya, Ali
    Sketch, Margaret
    Broderick, Meredith
    Hong, Taekwon
    Rao, Youlan
    Steen, Virginia
    CHEST, 2024, 166 (04) : 5756A - 5759A
12345